AstraZeneca vaccine comes with controversy; Everlywell acquires PWNHealth

This week's top stories include the AstraZeneca vaccine showing 79% efficacy but facing questions about using outdated information, Everlywell forming a new at-home lab testing subsidiary, and the VA reviewing its EHR modernization program.
By HIMSS TV
07:20 am
Share

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!